Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
批准号:
8010629
负责人:
Harold R Collard
金额:
$15.27万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-01 至 2012-12-31
关键词:
AcuteAddressAdult Respiratory Distress SyndromeBiologicalBiologyBlood Coagulation DisordersBlood specimenCharacteristicsClinicalClinical DataClinical ResearchClinical Trials NetworkCoagulation ProcessDevelopmentEnrollmentEnvironmentEtiologyFosteringFrequenciesFunctional disorderGoalsHamman-Rich syndromeIncidenceInterdisciplinary StudyInterstitial Lung DiseasesInvestigationKnowledgeMeasuresMedicalMentorshipModelingMorbidity - disease rateNational Heart, Lung, and Blood InstitutePatientsPositioning AttributePreventionPrevention approachProtocols documentationResearchResearch InfrastructureResearch PersonnelResearch ProposalsResourcesRiskRisk FactorsRoleScientistTechniquesTimeVirus Diseasescareer developmentclinically significantdesignexperienceinnovationinsightmortalitynoveloutcome forecastprognosticprospectiverespiratoryskillssound
中文摘要
这份K23提案的目的是为了让我作为一名临床研究员继续发展
目标是成为间质性肺病研究的独立领导者。在导师的指导下
小塔尔马奇·E·金博士。和Michael A.Matthay博士,并在经验丰富的网络的指导下
作为临床和基础研究人员,我将获得实现这一目标所需的经验和技能。
我设计的研究方案涉及定义特发性肺的急性加重
临床和生物学水平的纤维化(IPF)。间质性肺纤维化是一种常见且高度病态的间质性肺。
疾病,其中急性加重是一个重要组成部分。发病率、病因和临床
对急性加重的重要性仍知之甚少。最近,NHLBI创建了IPF
临床研究网络(IPFnet),允许对IPF进行大规模、设计良好的干预研究。通过
将我的研究计划定位为利用IPFnet主题和基础设施,我计划实现
以下四个具体目标:
目的1:了解特发性肺纤维化急性加重的发生率及危险因素。
目的2:明确隐匿性病毒感染在肺间质纤维化急性加重中的病因学作用。
目的3:探讨凝血功能紊乱在特发性肺纤维化急性加重中的作用。
目的4:探讨肺间质纤维化急性加重的预后意义。
为了达到这些目标,临床数据、呼吸道分泌物和血液样本将从
估计有150名IPF急性加重的受试者和适当的对照组。这项研究建议
可提供对急性加重的频率和原因的洞察,提供证据以供
设计预防和治疗的干预试验。重要的是,这项研究提案还将有助于
培养我的职业发展目标,获得未来临床工作的经验和专业知识
研究试验,掌握尖端的生物统计学技术,发展多学科
临床和基础科学家之间的合作。这些技能将使我充分认识到
临床研究,以了解基础生物学和提高医学知识。
英文摘要
The purpose of this K23 proposal is to allow for my continued development as a clinical researcher with the
goal of becoming an independent leader in the investigation of interstitial lung disease. Under the mentorship
of Dr. Talmadge E. King, Jr. and Dr. Michael A. Matthay, and with guidance from a network of experienced
clinical and basic researchers, I will obtain the experience and skills necessary to achieve this goal.
The research proposal I have designed involves defining acute exacerbations of Idiopathic Pulmonary
Fibrosis (IPF) at a clinical and biological level. IPF is a common and highly morbid form of interstitial lung
disease, of which acute exacerbations are an important component. The incidence, causes, and clinical
significance of acute exacerbations remain poorly understood. Recently, the NHLBI has created the IPF
Clinical Research Network (IPFNet) to allow for large-scale, well-designed interventional studies of IPF. By
positioning my research proposal to take advantage of IPFNet subjects and infrastructure, I plan to achieve
the following four specific aims:
Aim 1: To determine the incidence of and risk factors for acute exacerbations ofIPF.
Aim 2: To define the etiologic role of occult viral infection in acute exacerbations ofIPF.
Aim 3: To determine the role of disordered coagulation in acute exacerbations ofIPF.
Aim 4: To demonstrate the prognostic significance of acute exacerbations ofIPF.
To achieve these aims, clinical data, respiratory secretions, and blood samples will be collected from an
estimated 150 subjects with acute exacerbations of IPF and appropriate controls. This research proposal
may provide insight into the frequency and causes of acute exacerbations,providing evidence upon which to
design interventional trials of prevention and treatment. Importantly, this research proposal will also serve to
foster my career development goals of gaining experience and expertise in conducting prospective clinical
research trials, mastering sophisticated biostatistical techniques, and developing multidisciplinary
collaborations among clinical and basic scientists. These skills will allow me to fully realize the power of
clinical research to inform basic biology and advance medical knowledge.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s13665-013-0065-x
发表时间:
2013-12
期刊:
Current respiratory care reports
影响因子:
--
作者:
[Johannson, Kerri, Collard, Harold R]
通讯作者:
Collard, Harold R
DOI:
10.1186/1465-9921-13-105
发表时间:
2012-11-20
期刊:
Respiratory research
影响因子:
5.8
作者:
[Cha SI, Ryerson CJ, Lee JS, Kukreja J, Barry SS, Jones KD, Elicker BM, Kim DS, Papa FR, Collard HR, Wolters PJ]
通讯作者:
Wolters PJ
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.
DOI:
10.1016/j.rmed.2012.10.018
发表时间:
2013-02
期刊:
RESPIRATORY MEDICINE
影响因子:
4.3
作者:
[Lee, Joyce S., Kim, Eunice J., Lynch, Kara L., Elicker, Brett, Ryerson, Christopher J., Katsumoto, Tamiko R., Shum, Anthony K., Wolters, Paul J., Cerri, Stefania, Richeldi, Luca, Jones, Kirk D., King, Talmadge E., Jr., Collard, Harold R.]
通讯作者:
Collard, Harold R.
DOI:
10.1183/09031936.00122213
发表时间:
2014-04
期刊:
The European respiratory journal
影响因子:
--
作者:
[Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR]
通讯作者:
Collard HR
DOI:
10.1016/j.amjmed.2009.07.033
发表时间:
2010-04
期刊:
AMERICAN JOURNAL OF MEDICINE
影响因子:
5.9
作者:
[Lee, Joyce S., Collard, Harold R., Raghu, Ganesh, Sweet, Matthew P., Hays, Steven R., Campos, Guilherme M., Golden, Jeffrey A., King, Talmadge E., Jr.]
通讯作者:
King, Talmadge E., Jr.
共 6 条
Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children
-
批准号:10252845
-
项目类别:
-
资助金额:$204.8万
-
财政年份:2018
-
负责人:Harold R Collard
-
依托单位:
Clinical and Translational Science Institute
-
批准号:10448382
-
项目类别:
-
资助金额:$852.15万
-
财政年份:2016
-
负责人:Harold R Collard
-
依托单位:
Clinical and Translational Science Institute
-
批准号:10673045
-
项目类别:
-
资助金额:$847.67万
-
财政年份:2016
-
负责人:Harold R Collard
-
依托单位:
Patient Oriented Research and Mentoring in Interstitial Lung Disease
-
批准号:9756164
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2015
-
负责人:Harold R Collard
-
依托单位:
Patient Oriented Research and Mentoring in Interstitial Lung Disease
-
批准号:9334289
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2015
-
负责人:Harold R Collard
-
依托单位:
Patient Oriented Research and Mentoring in Interstitial Lung Disease
-
批准号:9142353
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2015
-
负责人:Harold R Collard
-
依托单位:
Patient Oriented Research and Mentoring in Interstitial Lung Disease
-
批准号:8867807
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2015
-
负责人:Harold R Collard
-
依托单位:
Treatment of IPF with Laparoscopic Anti-reflux Surgery
-
批准号:8544569
-
项目类别:
-
资助金额:$107.58万
-
财政年份:2013
-
负责人:Harold R Collard
-
依托单位:
Treatment of IPF with Laparoscopic Anti-reflux Surgery
-
批准号:8708207
-
项目类别:
-
资助金额:$194.23万
-
财政年份:2013
-
负责人:Harold R Collard
-
依托单位:
Treatment of IPF with Laparoscopic Anti-reflux Surgery
-
批准号:8856655
-
项目类别:
-
资助金额:$198.61万
-
财政年份:2013
-
负责人:Harold R Collard
-
依托单位:
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
-
批准号:7546539
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2007
-
负责人:Harold R Collard
-
依托单位:
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
-
批准号:7176639
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2007
-
负责人:Harold R Collard
-
依托单位:
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
-
批准号:7753852
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2007
-
负责人:Harold R Collard
-
依托单位:
Defining Acute Exacerbations of Idiopathic Pulmonary Fibrosis
-
批准号:7336272
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2007
-
负责人:Harold R Collard
-
依托单位:
Apoptotic Cell Removal in Idiopathic Pulmonary Fibrosis
-
批准号:6831107
-
项目类别:
-
资助金额:$5.03万
-
财政年份:2004
-
负责人:Harold R Collard
-
依托单位:
Longitudinal Cohort/Sheppard
-
批准号:8401279
-
项目类别:
-
资助金额:$40.0万
-
财政年份:--
-
负责人:Harold R Collard
-
依托单位:
Longitudinal Cohort/Sheppard
-
批准号:8527837
-
项目类别:
-
资助金额:$36.87万
-
财政年份:--
-
负责人:Harold R Collard
-
依托单位:
Longitudinal Cohort/Sheppard
-
批准号:8703758
-
项目类别:
-
资助金额:$37.93万
-
财政年份:--
-
负责人:Harold R Collard
-
依托单位:
海外基金